Anant Madabhushi

Shaker Heights, OH, United States of America

Anant Madabhushi

This inventor holds 111 USPTO granted patents and 19 published patent applications and 3 EPO patents, primarily in Radiomics And Imaging (CPC class G06T7-0012). Top assignees: Case Western Reserve University, Rutgers, The State University of New Jersey, The Cleveland Clinic Foundation. Active years: 2008-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anant Madabhushi. Retrieved from https://idiyas.com/inventor/anant-madabhushi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 111 

% Patents Active = 94.6

 

Average Co-Inventor Count = 3.1

ph-index = 11

Forward Citations = 693(Granted Patents)

Forward Citations (Not Self Cited) = 592(Dec 10, 2025)


Inventors with similar research interests:

🔬 See more inventors

Location History:

  • Philadelphia, PA (US) (2008)
  • South Plainfield, NJ (US) (2012 - 2017)
  • Beachwood, OH (US) (2015 - 2020)
  • Shaker Heighls, OH (US) (2023)
  • Shaker Heights, OH (US) (2017 - 2024)
  • Cleveland, OH (US) (2024)

Company Filing History:


Years Active: 2008-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Radiomics
Tumor Characterization
Image Analysis
Prognosis Prediction
Cancer Imaging
Machine Learning
Pathology
Deep Learning
Histology
Biopsy Features
Lymphocyte Phenotyping
MRI
111 patents (USPTO):Explore Patents

Anant Madabhushi from Shaker Heights, Ohio is a top inventor in the field of medical technology and image analysis. He has an impressive number of patents, with 89 currently credited to his name. Amongst his most recent patents are methods for predicting responses to immunotherapy and analyzing prostate glands using three-dimensional pathology images.

The first patent revolutionizes the treatment of non-small cell lung cancer by predicting whether a patient will respond to immunotherapy by analyzing nuclear radiomic features from a digitized image of cancerous tissue. The patent includes developing a nuclear cell graph based on the segmented cellular nuclei, which provides a set of features that are used to classify the patient as either a responder or non-responder to immunotherapy. This technology allows clinicians to make faster treatment decisions, and as a result, patients will have a higher chance of a successful recovery.

Madabhushi's next invention uses three-dimensional (3D) morphology features to analyze the prostate glands of a patient diagnosed with prostate cancer. By accessing a 3D optical image volume of the patient's prostate gland, the software can extract relevant features from the segmented image of the gland. These features include the Gleason score, prognosis, and classification of the prostate gland as benign or malignant. Medical practitioners can utilize this technology to prioritize treatment options and determine a patient's survival rate.

Madabhushi began his cutting-edge research on projects such as these while working at Case Western Reserve University and The Cleveland Clinic Foundation. He worked with fellow innovators Vamsidhar Velcheti and Mirabela Rusu, who was able to contribute to his unparalleled advancements in medical technology.

As the medical industry continues to push new boundaries, Madabhushi is on the front lines developing the latest technologies. His groundbreaking research demonstrates how technology can be used to revolutionize disease treatment and diagnosis and could potentially save countless lives.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…